168 related articles for article (PubMed ID: 19944695)
1. Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway.
Hirose A; Tanikawa T; Mori H; Okada Y; Tanaka Y
FEBS Lett; 2010 Jan; 584(1):61-6. PubMed ID: 19944695
[TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.
Wautier JL; Zoukourian C; Chappey O; Wautier MP; Guillausseau PJ; Cao R; Hori O; Stern D; Schmidt AM
J Clin Invest; 1996 Jan; 97(1):238-43. PubMed ID: 8550841
[TBL] [Abstract][Full Text] [Related]
3. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.
Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE
Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201
[TBL] [Abstract][Full Text] [Related]
4. Role of myosin light chain and myosin light chain kinase in advanced glycation end product-induced endothelial hyperpermeability in vitro and in vivo.
Wu F; Guo X; Xu J; Wang W; Li B; Huang Q; Su L; Xu Q
Diab Vasc Dis Res; 2016 Mar; 13(2):137-44. PubMed ID: 26607798
[TBL] [Abstract][Full Text] [Related]
5. Role of Src in Vascular Hyperpermeability Induced by Advanced Glycation End Products.
Zhang W; Xu Q; Wu J; Zhou X; Weng J; Xu J; Wang W; Huang Q; Guo X
Sci Rep; 2015 Sep; 5():14090. PubMed ID: 26381822
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of advanced glycation end products-induced hyperpermeability in endothelial cells].
Guo XH; Huang QB; Chen B; Wang SY; Hou FF; Fu N
Sheng Li Xue Bao; 2005 Apr; 57(2):205-10. PubMed ID: 15830106
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
Schmidt AM; Hori O; Chen JX; Li JF; Crandall J; Zhang J; Cao R; Yan SD; Brett J; Stern D
J Clin Invest; 1995 Sep; 96(3):1395-403. PubMed ID: 7544803
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin.
Okamoto T; Yamagishi S; Inagaki Y; Amano S; Koga K; Abe R; Takeuchi M; Ohno S; Yoshimura A; Makita Z
FASEB J; 2002 Dec; 16(14):1928-30. PubMed ID: 12368225
[TBL] [Abstract][Full Text] [Related]
9. Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability.
Breslin JW; Yuan SY
Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1057-62. PubMed ID: 14630629
[TBL] [Abstract][Full Text] [Related]
10. Effect of serum from patients with severe acute pancreatitis on vascular endothelial permeability.
Zheng YJ; Zhou B; Ding G; Wang ZC; Wang XQ; Wang YL; Tang YQ
Pancreas; 2013 May; 42(4):633-9. PubMed ID: 23303203
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory mechanism of ulinastatin: Inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-α via the RhoA/ROCK signal pathway.
Wei F; Liu S; Luo L; Gu N; Zeng Y; Chen X; Xu S; Zhang D
Int Immunopharmacol; 2017 May; 46():220-227. PubMed ID: 28329735
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Pharmacol Res; 2012 Mar; 65(3):297-302. PubMed ID: 22100460
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells.
Guo XH; Huang QB; Chen B; Wang SY; Li Q; Zhu YJ; Hou FF; Fu N; Brunk UT; Zhao M
APMIS; 2006 Dec; 114(12):874-83. PubMed ID: 17207088
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.
Li JH; Wang W; Huang XR; Oldfield M; Schmidt AM; Cooper ME; Lan HY
Am J Pathol; 2004 Apr; 164(4):1389-97. PubMed ID: 15039226
[TBL] [Abstract][Full Text] [Related]
15. Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat.
Sun M; Yokoyama M; Ishiwata T; Asano G
Int J Exp Pathol; 1998 Aug; 79(4):207-22. PubMed ID: 9797717
[TBL] [Abstract][Full Text] [Related]
16. Diabetic vascular disease: it's all the RAGE.
Hudson BI; Wendt T; Bucciarelli LG; Rong LL; Naka Y; Yan SF; Schmidt AM
Antioxid Redox Signal; 2005; 7(11-12):1588-600. PubMed ID: 16356122
[TBL] [Abstract][Full Text] [Related]
17. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs).
Collison KS; Parhar RS; Saleh SS; Meyer BF; Kwaasi AA; Hammami MM; Schmidt AM; Stern DM; Al-Mohanna FA
J Leukoc Biol; 2002 Mar; 71(3):433-44. PubMed ID: 11867681
[TBL] [Abstract][Full Text] [Related]
18. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
[TBL] [Abstract][Full Text] [Related]
19. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
20. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability.
Sun H; Breslin JW; Zhu J; Yuan SY; Wu MH
Microcirculation; 2006; 13(3):237-47. PubMed ID: 16627366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
